Jiangsu Hualan New Pharmaceutical Material Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 407.25 million compared to CNY 642.41 million a year ago. Revenue was CNY 407.25 million compared to CNY 642.41 million a year ago.

Net income was CNY 76.65 million compared to CNY 184.61 million a year ago. Basic earnings per share from continuing operations was CNY 0.569 compared to CNY 1.828 a year ago. Diluted earnings per share from continuing operations was CNY 0.569 compared to CNY 1.828 a year ago.